BNET Industries
- Private
Contact Information
NAICS Code Colleges, Universities, and Professional Schools: 611310
Recent Events
-
UTSA adopts Click Commerce’s research, compliance software
-
Sole Finalist Named for UTPA President Position
-
Collaboration creates 250 jobs in Richardson
-
Gophers to Play Texas at TCF Bank Stadium in 2015
-
Tech research at UT in line for $2M in funding
-
Tech receives $21.5 million bonus from state for research
-
Pearson Foundation's $1 Million Donation Will Create an Applied Psychometric Research Center at The University...
-
RF Code Announces First Ever Wire-Free Liquid Detection Sensor
-
In the race to turn back the biological clock, consumers are reaching for an unproven...
-
TerraTherm, Inc.: TerraTherm Royalty Payments to The University of Texas at Austin Top $1 Million...
-
Dallas-based Rainbow Days to put on Kids University summer camp
News & Analysis
Filter by
patient and university of texas - All News and Analysis
Castle Biosciences Signs Option Agreement for Brain Cancer Test with The University of Texas M.D. Anderson Cancer Center
- 2008-10-07
- Brain cancer test is a molecular diagnostic test developed and validated at The University of Texas M.D. Anderson Cancer Center to prospectively demonstrate responsiveness to treatment for glioblastoma multiforme GBM, the most common form of primary brain cancer - HOUSTON -- Castle Biosciences, a recently formed, rapidly growing,...
Delcath Expands Multi-Center Phase III Trial for Metastatic Melanoma
- 2008-06-24
Delcath Systems, Inc. (NASDAQ: DCTH) announced today that the University of Texas Medical Branch at Galveston UTMB, part of the University of Texas System, has joined Delcath's Phase III clinical trial for the treatment of inoperable metastatic melanoma in the liver using the Company's Percutaneous Hepatic Perfusion PHP System for...
Endourologists Now Have a New Category of Device For Stone Extraction to Help Render Patients Free from Kidney Stones and Stones in the Urinary Tract
- 2008-04-29
NGage[TM] Nitinol Stone Extractor from Cook Medical Combines Stone Graspers and Baskets Enables Greater Function and Control During Stone Retrieval Procedures BLOOMINGTON, Ind. -- The NGage Nitinol Stone Extractor, engineered and manufactured by Cook Medical , represents an entirely new category in the evolution of stone extraction. Utilizing Cook's...
BayPoint Biosystems Acquires Exclusive Commercial Rights to Proteomic Patent Portfolio from the University of Texas M. D. Anderson Cancer Center
- 2008-03-27
HOUSTON -- BayPoint Biosystems Inc., a privately held personalized medicine company, announced today that it has entered into a technology licensing agreement with the University of Texas M. D. Anderson Cancer Center. Under the terms of the agreement, BayPoint obtains exclusive, worldwide commercial rights to certain proteomic technologies as well...
How the University of Texas Medical Branch responded to changing demographics
- 2007-12-27
PROBLEM In 2005, the University of Texas Medical Branch in Galveston was struggling to serve the ever-increasing Hispanic population of the state, dealing with growing health disparities between Whites and Hispanics and trying to find a way to satiate the interest of students seeking to learn medical Spanish. ...
BG Medicine Forms Research Collaboration with M.D. Anderson Cancer Center to Discover Serum Biomarkers for Breast Cancer Treatment Response
- 2007-05-09
WALTHAM, Mass. -- BG Medicine announced today that it has entered into a research collaboration with The University of Texas M. D. Anderson Cancer Center aimed at improving the treatment of breast cancer. Under this agreement, BG Medicine will apply its biomarker discovery technology to the analysis of clinical samples...
Introgen's Intravenous Nanoparticle Gene Therapy Shows Activity in Stage IV Lung Cancer Patients
- 2007-04-17
Clinical Data Selected for Late-Breaking Session at AACR Cancer Conference LOS ANGELES -- A cancer-suppressing gene has been successfully delivered into the tumors of stage IV lung cancer patients via Introgen Therapeutics, Inc.'s (NASDAQ:INGN) intravenously administered lipid nanoparticle product candidate INGN 401. In a phase 1 clinical trial conducted...
M. D. Anderson Cancer Center Selects PHNS
- 2006-08-14
DALLAS -- The University of Texas M. D. Anderson Cancer Center, one of the world's most respected cancer centers, has selected PHNS to provide remote health information coding services. PHNS will access M. D. Anderson's electronic health records through a remote-access virtual private network to exchange patient information in a...
University of Texas Places Substantial Order with InforMedix; Med-eMonitor System to Monitor Medication and Care Plan Adherence in 200 Schizophrenic Patients
- 2006-08-14
ROCKVILLE, Md. -- InforMedix Holdings, Inc. (OTCBB: IFMX), creating a new technology platform that improves medication adherence and enables patients to manage chronic illnesses at home, today announced plans that its patented Med-eMonitorTM System will be used to improve the monitoring and care of 200 schizophrenic patients in San Antonio,...
Hitachi ''PROBEAT'' Proton Beam Therapy System Now Online Treating Patients at the University of Texas, M. D. Anderson Cancer Center
- 2006-06-30
BRISBANE, Calif. -- Hitachi, Ltd. (NYSE:HIT) and its subsidiary, Hitachi America, Ltd., today announced the successful startup of the company's "PROBEAT" proton beam therapy system for the treatment of certain types of cancers at The University of Texas M. D. Anderson Cancer Center in Houston, Texas. Hitachi supplied the major...
Glass Door
| Company | Employer Rating |
| Alcoa |  |
| CBS Corp |  |
| Johnson & Johnson | |
| Costco Wholesale |  |
|
IndustryTop Rated
